129 related articles for article (PubMed ID: 20065948)
1. Inhibiting nonmuscle myosin II impedes inflammatory infiltration and ameliorates progressive renal disease.
Si J; Ge Y; Zhuang S; Gong R
Lab Invest; 2010 Mar; 90(3):448-58. PubMed ID: 20065948
[TBL] [Abstract][Full Text] [Related]
2. Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes.
Zhang M; Rao PV
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4130-8. PubMed ID: 16249490
[TBL] [Abstract][Full Text] [Related]
3. Blebbistatin, a myosin II inhibitor, is photoinactivated by blue light.
Sakamoto T; Limouze J; Combs CA; Straight AF; Sellers JR
Biochemistry; 2005 Jan; 44(2):584-8. PubMed ID: 15641783
[TBL] [Abstract][Full Text] [Related]
4. NMMHC IIA inhibition impedes tissue factor expression and venous thrombosis via Akt/GSK3β-NF-κB signalling pathways in the endothelium.
Zhai K; Tang Y; Zhang Y; Li F; Wang Y; Cao Z; Yu J; Kou J; Yu B
Thromb Haemost; 2015 Jul; 114(1):173-85. PubMed ID: 25881103
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of myosin IIA-actin interaction prevents ischemia/reperfusion induced cardiomyocytes apoptosis through modulating PINK1/Parkin pathway and mitochondrial fission.
Li F; Fan X; Zhang Y; Zhang Y; Ma X; Kou J; Yu B
Int J Cardiol; 2018 Nov; 271():211-218. PubMed ID: 30144997
[TBL] [Abstract][Full Text] [Related]
6. Nonmuscle myosin II inhibition disrupts methamphetamine-associated memory in females and adolescents.
Young EJ; Briggs SB; Rumbaugh G; Miller CA
Neurobiol Learn Mem; 2017 Mar; 139():109-116. PubMed ID: 28082169
[TBL] [Abstract][Full Text] [Related]
7. Myosin IIA interacts with the spectrin-actin membrane skeleton to control red blood cell membrane curvature and deformability.
Smith AS; Nowak RB; Zhou S; Giannetto M; Gokhin DS; Papoin J; Ghiran IC; Blanc L; Wan J; Fowler VM
Proc Natl Acad Sci U S A; 2018 May; 115(19):E4377-E4385. PubMed ID: 29610350
[TBL] [Abstract][Full Text] [Related]
8. Targeting non-muscle myosin II promotes corneal endothelial migration through regulating lamellipodial dynamics.
Ho WT; Chang JS; Chou SF; Hwang WL; Shih PJ; Chang SW; Yang MH; Jou TS; Wang IJ
J Mol Med (Berl); 2019 Sep; 97(9):1345-1357. PubMed ID: 31302714
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of pancreatic adenocarcinoma cellular invasiveness by blebbistatin: a novel myosin II inhibitor.
Duxbury MS; Ashley SW; Whang EE
Biochem Biophys Res Commun; 2004 Jan; 313(4):992-7. PubMed ID: 14706640
[TBL] [Abstract][Full Text] [Related]
10. Functions of nonmuscle myosin II in assembly of the cellular contractile system.
Shutova M; Yang C; Vasiliev JM; Svitkina T
PLoS One; 2012; 7(7):e40814. PubMed ID: 22808267
[TBL] [Abstract][Full Text] [Related]
11. Correlation of dysfunction of nonmuscle myosin IIA with increased induction of Cyp1a1 in Hepa-1 cells.
Ebina M; Shibazaki M; Kudo K; Kasai S; Kikuchi H
Biochim Biophys Acta; 2011 Mar; 1809(3):176-83. PubMed ID: 21216307
[TBL] [Abstract][Full Text] [Related]
12. The role of myosin II motor activity in distributing myosin asymmetrically and coupling protrusive activity to cell translocation.
Kolega J
Mol Biol Cell; 2006 Oct; 17(10):4435-45. PubMed ID: 16855019
[TBL] [Abstract][Full Text] [Related]
13. Specificity of blebbistatin, an inhibitor of myosin II.
Limouze J; Straight AF; Mitchison T; Sellers JR
J Muscle Res Cell Motil; 2004; 25(4-5):337-41. PubMed ID: 15548862
[TBL] [Abstract][Full Text] [Related]
14. Mertk drives myosin II redistribution during retinal pigment epithelial phagocytosis.
Strick DJ; Feng W; Vollrath D
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2427-35. PubMed ID: 19117932
[TBL] [Abstract][Full Text] [Related]
15. Nonmuscle Myosin II Activation Regulates Cell Proliferation, Cell Contraction, and Myofibroblast Differentiation in Keloid-Derived Fibroblasts.
Lu YY; Fang CC; Hong CH; Wu CH; Lin YH; Chang KL; Lee CH
Adv Wound Care (New Rochelle); 2020 Sep; 9(9):491-501. PubMed ID: 32941122
[No Abstract] [Full Text] [Related]
16. Megalin and nonmuscle myosin heavy chain IIA interact with the adaptor protein Disabled-2 in proximal tubule cells.
Hosaka K; Takeda T; Iino N; Hosojima M; Sato H; Kaseda R; Yamamoto K; Kobayashi A; Gejyo F; Saito A
Kidney Int; 2009 Jun; 75(12):1308-1315. PubMed ID: 19340093
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of Nonmuscle myosin II-A regulatory light chain resists Sendai virus fusion with host cells.
Das P; Saha S; Chandra S; Das A; Dey SK; Das MR; Sen S; Sarkar DP; Jana SS
Sci Rep; 2015 May; 5():10395. PubMed ID: 25993465
[TBL] [Abstract][Full Text] [Related]
18. NMMHC IIA triggers neuronal autophagic cell death by promoting F-actin-dependent ATG9A trafficking in cerebral ischemia/reperfusion.
Wang G; Wang T; Hu Y; Wang J; Wang Y; Zhang Y; Li F; Liu W; Sun Y; Yu B; Kou J
Cell Death Dis; 2020 Jun; 11(6):428. PubMed ID: 32513915
[TBL] [Abstract][Full Text] [Related]
19. Blebbistatin inhibits the chemotaxis of vascular smooth muscle cells by disrupting the myosin II-actin interaction.
Wang HH; Tanaka H; Qin X; Zhao T; Ye LH; Okagaki T; Katayama T; Nakamura A; Ishikawa R; Thatcher SE; Wright GL; Kohama K
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2060-8. PubMed ID: 18296570
[TBL] [Abstract][Full Text] [Related]
20. Cytoskeletal coherence requires myosin-IIA contractility.
Cai Y; Rossier O; Gauthier NC; Biais N; Fardin MA; Zhang X; Miller LW; Ladoux B; Cornish VW; Sheetz MP
J Cell Sci; 2010 Feb; 123(Pt 3):413-23. PubMed ID: 20067993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
